a public good project by the
Synthesis
Company
of California

© 2026

Andrew Arnold | doi.page

0 works0 citations0 h-index

Andrew Arnold

University of Connecticut(US)Molecular Oncology (United States)(US)UConn Health(US)

Publications by Year

Research Areas

Parathyroid Disorders and Treatments, Genetic Syndromes and Imprinting, Pancreatic and Hepatic Oncology Research, Cancer-related Molecular Pathways, Neuroendocrine Tumor Research Advances

Most-Cited Works

→ A novel cyclin encoded by a bcl1-linked candidate oncogene(1991)1,281 cited
→ Regulation of retinoblastoma protein functions by ectopic expression of human cyclins(1992)1,008 cited
→ Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice(1994)974 cited
→ The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer(2001)891 cited
→ Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions(1995)804 cited
→ Physical interaction of the retinoblastoma protein with human D cyclins(1993)761 cited

→ Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.(1993)

725 cited

→ Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.(1988)699 cited

→ Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.(1998)623 cited

→ Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid Neoplasms(1983)610 cited